Héloïse Bourien
Héloïse Bourien publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis and Cancer Genomics and Diagnostics.
- World rank
- #2,337,177 of 7,710,434 ranked researchers
- Rank in France
- #100,311 of 324,115
- Works
- 56
- Citations
- 628
- Citations per work
- 11.2
What does Héloïse Bourien research?
Héloïse Bourien's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3563.0%
- Medicine3563.0%
- Everything else1222.0%
- Life Sciences815.0%
- 1Pulmonary and Respiratory Medicine18% of their works
- 2Oncology18% of their works
- 3Surgery15% of their works
- 4Hepatology12% of their works
- 5Molecular Biology8% of their works
- 6Cancer Research8% of their works
Research topics
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Genomics and Diagnostics
- Gallbladder and Bile Duct Disorders
- Colorectal Cancer Treatments and Studies
- Advanced Breast Cancer Therapies
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Which keywords describe Héloïse Bourien's research?
The keywords of their largest research topics: Cholangiocarcinoma, Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma, Liver Cancer, Chemotherapy, Tumor Microenvironment and Cancer Genomics.
- Pancreatic Cancer
- Immune Checkpoint Blockade
- Cetuximab
- Breast Cancer
- Cholecystitis
- Cancer Genomics
- Chemotherapy
- Hepatocellular Carcinoma
- Biliary Tract Cancer
- Cholangiocarcinoma
- Intrahepatic Cholangiocarcinoma
- Liver Cancer
- Tumor Microenvironment
- Mutational Signatures
- ERCP
- CDK4/6 Inhibitors
- KRAS Mutations
- PD-1 and PD-L1
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cholangiocarcinoma212 topics
- Biliary Tract Cancer141 topic
- Intrahepatic Cholangiocarcinoma141 topic
- Hepatocellular Carcinoma131 topic
- Liver Cancer131 topic
- Chemotherapy112 topics
- Tumor Microenvironment102 topics
- Cancer Genomics81 topic
- Mutational Signatures81 topic
- Cholecystitis71 topic
- ERCP71 topic
- Breast Cancer61 topic
- CDK4/6 Inhibitors61 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
- Pancreatic Cancer51 topic
- Surgical Complications51 topic
Where does Héloïse Bourien work?
Héloïse Bourien's main affiliation in the publication record is Centre Eugène Marquis, France.
How many publications and citations does Héloïse Bourien have?
OpenAlex counts 56 works and 628 citations for Héloïse Bourien, an h-index of 11, ranking #2,337,177 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Héloïse Bourien. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.